The Jan Vishwas (Amendment of Provisions) Act, 2026 represents a paradigm shift from punitive to trust-based governance. Critically examine its implications for regulatory enforcement in India's health sector.

Q. The Jan Vishwas (Amendment of Provisions) Act, 2026 represents a paradigm shift from punitive to trust-based governance. Critically examine its implications for regulatory enforcement in India's health sector. (15 marks, 250-350 words)

The Jan Vishwas (Amendment of Provisions) Act, 2026 amends 80 Central Acts to decriminalise or rationalise offences, replacing imprisonment for minor lapses with civil penalties [3]. Its operationalisation in the health sector in June 2026 signals a genuine shift towards proportionate, trust-based regulation — though the shift is partial and capacity-dependent.

Evidence of a paradigm shift - Five health statutes are covered — the Drugs and Cosmetics Act, 1940, Pharmacy Act, 1948, Food Safety and Standards Act, 2006, Clinical Establishments Act, 2010 and NCAHP Act, 2021 [1]. - Minor cosmetics violations (other than spurious or adulterated products) move out of courts into a civil penalty framework [1]. - For the first time, adjudicating authorities are appointed by the Central and State Governments, with show-cause notice, personal hearing and an appellate mechanism [1]. - Redundant provisions are pruned — e.g. Section 29 of the Drugs Act, penalising advertising use of a Government Analyst's report, stands omitted [1]; obstruction of Food Safety Officers is left to the Bharatiya Nyaya Sanhita, 2023 [2].

Gains for regulatory enforcement - Proportionality: criminal liability is reserved for conduct that actually endangers health, easing needless prosecution of pharmacists, food vendors and MSMEs over paperwork [2]. - Deterrence retained: penalties escalate automatically every three years, and offences involving spurious drugs or unsafe food remain fully criminal [1][3]. - Predictability for India's large pharmaceutical and food-processing base, aiding investment.

Critical concerns - Risk of under-deterrence if adjudicating authorities are understaffed or industry-influenced; monetary penalties may be absorbed as a cost of business. - Drugs and food safety are enforced largely by State FDAs and food safety commissioners, whose institutional capacity varies widely. - Administrative adjudication needs trained officers and transparent, reasoned orders to satisfy Article 14 standards.

The Act's worth therefore lies less in decriminalisation itself than in what replaces it. Trust becomes credible only when paired with capable adjudication — well-staffed State regulators, published penalty orders and strengthened laboratory testing. Executed thus, it advances both ease of doing business and the right to health under Article 21.

(~325 words)

Sources: 1. Government Operationalises Jan Vishwas Act Reforms in Health Sector — PIB, MoHFW, 26 June 2026 — five health statutes covered, civil penalty route for minor cosmetics violations, adjudicating authorities with hearing and appeal, omission of Section 29, retention of criminal liability for spurious/adulterated products 2. Jan Vishwas (Amendment of Provisions) Bill, 2026: Rationalizing Compliance and Decriminalizing Minor Offences in the Health Sector — PIB, April 2026 — compliance-burden relief for small businesses; obstruction of Food Safety Officers subsumed under the Bharatiya Nyaya Sanhita, 2023 3. The Jan Vishwas (Amendment of Provisions) Bill, 2026 — PRS Legislative Research — 80 Central Acts amended, imprisonment replaced by civil penalties, automatic revision of fines every three years